Cargando…

Best practice in nurse-led chemotherapy review: a position statement from the United Kingdom Oncology Nursing Society

This position statement has been formulated by nurses from the United Kingdom Oncology Nursing Society (UKONS) to provide guidance on the provision of nurse-led chemotherapy review clinics for adult patients. For the purposes of this statement, a nurse-led chemotherapy clinic is defined as one that...

Descripción completa

Detalles Bibliográficos
Autores principales: Lennan, E, Vidall, C, Roe, H, Jones, P, Smith, J, Farrell, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413734/
https://www.ncbi.nlm.nih.gov/pubmed/22879834
http://dx.doi.org/10.3332/ecancer.2012.263
_version_ 1782240108817154048
author Lennan, E
Vidall, C
Roe, H
Jones, P
Smith, J
Farrell, C
author_facet Lennan, E
Vidall, C
Roe, H
Jones, P
Smith, J
Farrell, C
author_sort Lennan, E
collection PubMed
description This position statement has been formulated by nurses from the United Kingdom Oncology Nursing Society (UKONS) to provide guidance on the provision of nurse-led chemotherapy review clinics for adult patients. For the purposes of this statement, a nurse-led chemotherapy clinic is defined as one that conducts formal review (in a consultation room) before the decision to proceed and prescribe the next cycle of chemotherapy. This statement does not address the toxicity checks that take place immediately prior to the administration of chemotherapy, although many of the same principles will apply to both settings.
format Online
Article
Text
id pubmed-3413734
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-34137342012-08-09 Best practice in nurse-led chemotherapy review: a position statement from the United Kingdom Oncology Nursing Society Lennan, E Vidall, C Roe, H Jones, P Smith, J Farrell, C Ecancermedicalscience Policy This position statement has been formulated by nurses from the United Kingdom Oncology Nursing Society (UKONS) to provide guidance on the provision of nurse-led chemotherapy review clinics for adult patients. For the purposes of this statement, a nurse-led chemotherapy clinic is defined as one that conducts formal review (in a consultation room) before the decision to proceed and prescribe the next cycle of chemotherapy. This statement does not address the toxicity checks that take place immediately prior to the administration of chemotherapy, although many of the same principles will apply to both settings. Cancer Intelligence 2012-07-31 /pmc/articles/PMC3413734/ /pubmed/22879834 http://dx.doi.org/10.3332/ecancer.2012.263 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Policy
Lennan, E
Vidall, C
Roe, H
Jones, P
Smith, J
Farrell, C
Best practice in nurse-led chemotherapy review: a position statement from the United Kingdom Oncology Nursing Society
title Best practice in nurse-led chemotherapy review: a position statement from the United Kingdom Oncology Nursing Society
title_full Best practice in nurse-led chemotherapy review: a position statement from the United Kingdom Oncology Nursing Society
title_fullStr Best practice in nurse-led chemotherapy review: a position statement from the United Kingdom Oncology Nursing Society
title_full_unstemmed Best practice in nurse-led chemotherapy review: a position statement from the United Kingdom Oncology Nursing Society
title_short Best practice in nurse-led chemotherapy review: a position statement from the United Kingdom Oncology Nursing Society
title_sort best practice in nurse-led chemotherapy review: a position statement from the united kingdom oncology nursing society
topic Policy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413734/
https://www.ncbi.nlm.nih.gov/pubmed/22879834
http://dx.doi.org/10.3332/ecancer.2012.263
work_keys_str_mv AT lennane bestpracticeinnurseledchemotherapyreviewapositionstatementfromtheunitedkingdomoncologynursingsociety
AT vidallc bestpracticeinnurseledchemotherapyreviewapositionstatementfromtheunitedkingdomoncologynursingsociety
AT roeh bestpracticeinnurseledchemotherapyreviewapositionstatementfromtheunitedkingdomoncologynursingsociety
AT jonesp bestpracticeinnurseledchemotherapyreviewapositionstatementfromtheunitedkingdomoncologynursingsociety
AT smithj bestpracticeinnurseledchemotherapyreviewapositionstatementfromtheunitedkingdomoncologynursingsociety
AT farrellc bestpracticeinnurseledchemotherapyreviewapositionstatementfromtheunitedkingdomoncologynursingsociety